Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier-Reference-Cited by-同舟云学术

Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier

Published:2024-02 Issue: Volume:56 Page:102731
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Werner Julia,Umstätter Florian,Hertlein Tobias,Beijer Barbro,Kleist Christian,Mühlberg Eric,Zimmermann Stefan,Haberkorn Uwe,Ohlsen Knut,Fricker Gert,Mier Walter,Uhl Philipp

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference52 articles.

1. The antimicrobial resistance crisis: causes, consequences, and management;Michael;Front Public Heal,2014

2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis;Murray;Lancet,2022

3. The review on antimicrobial resistance;O’Neill;Arch Pharm Pract,2016

4. Will 10 million people die a year due to antimicrobial resistance by 2050?;de Kraker;PLoS Med,2016

5. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis;Cassini;Lancet Infect Dis,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering Antimicrobial Peptides: Harnessing Nanotechnology and Engineering Strategies to Combat Microbial Resistance;Peptide Science;2024-08-02

2. P-gp inhibition and enhanced oral bioavailability of amikacin Sulfate: A novel approach using Thiolated Chito-PEGylated Lipidic Hybrids;International Journal of Pharmaceutics;2024-06

3. Oral Delivery of the Vancomycin Derivative FU002 by a Surface‐Modified Liposomal Nanocarrier;Advanced Healthcare Materials;2024-03